Jenscare LuX-Valve Plus

Lux-Valve Plus is an innovative tricuspid valve (TTVR) transcatheter replacement system developed by the Chinese biomedical company Jenscare Scientific.

It is specifically designed to treat minimally invasively patients with severe tricuspid insufficiency who present a high surgical risk for open heart surgery.

• Independent anchoring of the radial force: Unlike other prostheses that depend on expanding under pressure against the walls (which can damage the sensitive tissue), the LuX-Valve is held by means of a unique mechanism of clamps (collolly called “rabbit ears” or rabbit ears) that hold the veils of the native valve, added to a septal anchor that is fixed to the interventricular septum.
• Transjugular access (LuX-Valve Plus): the device obtained CE MDR certification from the European Union in July 2026. It is introduced through the internal jugular vein in the neck, offering a much more direct path to the tricuspid valve, which reduces the time of the procedure and the trauma in the heart. Security in their movements is given by a stabilizing system that adjusts to one side of the angiographic table.
• Large dimensions: It offers a wide range of sizes (from 40 to 70 mm), which allows to treat very dilated anatomies that previously did not have therapeutic options.

Impact and clinical benefits

Global clinical studies (such as the TRINITY trial) have shown that the device drastically reduces heart failure and significantly improves short- and long-term quality of life. By avoiding the need for open chest surgery and the use of extracorporeal circulation, patients experience a much faster recovery and less pain.